Literature DB >> 26226911

Pancreatic Cancer.

Brian M Wolpin1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26226911     DOI: 10.1016/j.hoc.2015.06.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


× No keyword cloud information.
  5 in total

1.  Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Cancer by Regulating RNA Binding Motif Protein 14.

Authors:  Shuxian Zhang; Qingqing Li; Huixiao Yuan; Ling Ren; Xuyang Liang; Shouying Li; Shengxiang Lv; Hua Jiang
Journal:  J Oncol       Date:  2022-05-27       Impact factor: 4.501

2.  Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway.

Authors:  Min Huang; Cheng Yi; Xian-Zhou Huang; Juan Yan; Li-Jia Wei; Wei-Ju Tang; Shou-Chun Chen; Ying Huang
Journal:  Oncol Lett       Date:  2021-04-01       Impact factor: 2.967

3.  Effects of lncRNA LINC01320 on Proliferation and Migration of Pancreatic Cancer Cells through Targeted Regulation of miR-324-3p.

Authors:  Hua Meng; Kun Guo; Yun Zhang
Journal:  J Healthc Eng       Date:  2021-12-23       Impact factor: 2.682

4.  Comprehensive Analysis of SMC Gene Family Prognostic Value and Immune Infiltration in Patients With Pancreatic Adenocarcinoma.

Authors:  Hui Nie; Yanhao Wu; Chunlin Ou; Xiaoyun He
Journal:  Front Med (Lausanne)       Date:  2022-03-15

5.  Clinical Significance of Color Ultrasound, MRI, miR-21, and CA199 in the Diagnosis of Pancreatic Cancer.

Authors:  Jing Yu; Xue Yang; Hongmei Wu; Jiansheng Li
Journal:  J Oncol       Date:  2021-07-28       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.